Illustrative image – not actual.British drug-maker, GlaxoSmithKline (GSK), is planning to set up a new drug manufacturing unit in India.
The company will invest Rs 864 crore and is scouting for a location in the country. The project is expected to be operationalised by 2017. Once the project gets commissioned, it will produce pharmaceutical products for the Indian market at a rate of eight billion tablets and one billion capsules per year. The facility will include a warehouse, site infrastructure and utilities to support the manufacturing and packing of the medicines.
Currently in India, the company has three consumer healthcare product factories at Nabha in Punjab, at Sonepat in Haryana, and at Rajahmundry in Andhra Pradesh. It also has one vaccines packaging unit and one pharmaceutical products plant in Nashik, Maharashtra.
